The frustrating truth is that most DSIP failures have nothing to do with the peptide itself
Huannao Yicong formula (HYF) and Jiannao Yizhi formula (JYF) reduce A42 and tau protein levels, delivering comparable benefits to standard ChEIs (Yang et al., 2019
Understanding these differences is essential when considering whether combination therapy might offer additional benefits for patients struggling with obesity and its associated health complications
Long-term Outcomes of Transoral Outlet Reduction (TORe) for Dumping Syndrome and Weight Regain After Roux-en-Y Gastric Bypass
Constantly switching between a single-agonist (semaglutide) and a dual-agonist (tirzepatide) can disrupt this equilibrium, making it harder for your provider to determine which medication is actually working or which one is causing specific side effects
Hospitals dominated the end-user segment with a market share of 44.26% in 2025, driven by high patient volumes, increasing diabetes management programs, growing obesity treatment initiatives, and greater access to specialist endocrinology services
